FI925353A0 - Foerfarande foer framstaellning av en vattenloesning - Google Patents

Foerfarande foer framstaellning av en vattenloesning

Info

Publication number
FI925353A0
FI925353A0 FI925353A FI925353A FI925353A0 FI 925353 A0 FI925353 A0 FI 925353A0 FI 925353 A FI925353 A FI 925353A FI 925353 A FI925353 A FI 925353A FI 925353 A0 FI925353 A0 FI 925353A0
Authority
FI
Finland
Prior art keywords
vattenloesning
framstaellning
framework
pentyloxyphenyl
thiazolidine
Prior art date
Application number
FI925353A
Other languages
English (en)
Other versions
FI100694B (fi
FI925353A (fi
Inventor
Hisayuki Nakayama
Kazumichi Ushio
Katsuhiro Inada
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of FI925353A publication Critical patent/FI925353A/fi
Publication of FI925353A0 publication Critical patent/FI925353A0/fi
Application granted granted Critical
Publication of FI100694B publication Critical patent/FI100694B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lasers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI925353A 1991-03-27 1992-11-25 Menetelmä vesisuspension valmistamiseksi FI100694B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6290991 1991-03-27
JP6290991 1991-03-27
JP9100932 1991-07-11
PCT/JP1991/000932 WO1992017174A1 (en) 1991-03-27 1991-07-11 Process for preparing aqueous suspension

Publications (3)

Publication Number Publication Date
FI925353A FI925353A (fi) 1992-11-25
FI925353A0 true FI925353A0 (fi) 1992-11-25
FI100694B FI100694B (fi) 1998-02-13

Family

ID=13213855

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925353A FI100694B (fi) 1991-03-27 1992-11-25 Menetelmä vesisuspension valmistamiseksi

Country Status (14)

Country Link
US (1) US5366985A (fi)
EP (1) EP0531529B1 (fi)
KR (1) KR0181973B1 (fi)
AT (1) ATE145328T1 (fi)
AU (2) AU650889B2 (fi)
CA (1) CA2083842A1 (fi)
DE (1) DE69123248T2 (fi)
DK (1) DK0531529T3 (fi)
ES (1) ES2094227T3 (fi)
FI (1) FI100694B (fi)
NO (1) NO301215B1 (fi)
RU (1) RU2098094C1 (fi)
TW (1) TW207500B (fi)
WO (1) WO1992017174A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284030B1 (it) * 1996-06-18 1998-05-08 Solchem Italiana Spa Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
WO1998051281A1 (fr) 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Preparations a base de suspensions aqueuses possedant d'excellentes proprietes de redispersion
EP1172097B1 (en) * 1999-04-12 2004-09-08 Shionogi & Co., Ltd. Process for producing medicinal composition of a basic hydrophobic medicinal compound
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839898C (en) * 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions

Also Published As

Publication number Publication date
AU6188894A (en) 1994-06-30
AU650889B2 (en) 1994-07-07
NO301215B1 (no) 1997-09-29
DK0531529T3 (da) 1997-04-21
FI100694B (fi) 1998-02-13
AU8104791A (en) 1992-11-02
KR0181973B1 (ko) 1999-05-01
EP0531529A1 (en) 1993-03-17
ES2094227T3 (es) 1997-01-16
EP0531529A4 (en) 1993-08-04
NO924549D0 (no) 1992-11-25
KR930700097A (ko) 1993-03-13
ATE145328T1 (de) 1996-12-15
DE69123248D1 (de) 1997-01-02
FI925353A (fi) 1992-11-25
US5366985A (en) 1994-11-22
EP0531529B1 (en) 1996-11-20
RU2098094C1 (ru) 1997-12-10
WO1992017174A1 (en) 1992-10-15
TW207500B (fi) 1993-06-11
AU661944B2 (en) 1995-08-10
NO924549L (no) 1992-11-25
CA2083842A1 (en) 1992-09-28
DE69123248T2 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
DE69126350D1 (de) Verfahren zur Herstellung von Chlorothiazolderivaten
NO932745L (no) Triazolyltiometyltiocefalosporinhydroklorid, dets krystalliske hydrat samt fremgangsmaate for fremstilling
NO177845C (no) Fremgangsmåte for fremstilling av et preparat for öyedråper
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
FI925353A0 (fi) Foerfarande foer framstaellning av en vattenloesning
NO982078L (no) FremgangsmÕte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formÕl
PL235576A1 (en) Process for preparing derivatives of penicillanic acid
RU92016488A (ru) Способ получения водной суспензии
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
YU46708B (sh) Postupak za dobijanje antibakterijskih derivata 9-dezoksi-9a-alil i propagril-9a-aza-9ahomoeritromicina
DE59002880D1 (de) Kristalline cephem saeureadditionssalze und verfahren zu ihrer herstellung.
WO1990003172A3 (en) Bile acids for treatment of viral infections
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
ATE133335T1 (de) Neuroprotektivum
DK486988D0 (da) Pyridylethanolaminer, deres fremstilling og laegemidler indeholdende forbindelserne
HU908017D0 (en) Process for the preparation of naphloxazines and medical preparation made of them
DE58902264D1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
HU912862D0 (en) Process for producing pharmaceutical compositions comprising substituted 2-cyclohexene derivatives
ATE139781T1 (de) Polare cephalosporinderivate und verfahren zu ihrer herstellung
ZA9010151B (en) Imidazolyl propyl guanidine derivative,a process for its preparation and a pharmaceutical composition containing this compound
ATE143963T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung
JPS6426501A (en) Growth controlling agent for sugar cane